Hands struggling with your phone? CBD cream has 'great potential' to help

YORKSHIRE, U.K. - Sept. 22, 2025 - PRLog -- Elderly people who are struggling to use their mobile phones due to osteoarthritis in their hands could benefit from CBD creams and gels, according to scientific studies.

The study, published in Nature, found that transdermal CBD gel can improve hand pain and grip strength in people with symptomatic hand osteoarthritis.

HempWell, a leading supplier of CBD products, has long known of the connection between pain relief and CBD creams.

Noted medical cannabis expert Professor Mike Barnes, a former Consultant Neurologist and currently the Scientific Advisor to HempWell, said the study "shows the great potential for CBD gels and creams."

Professor Barnes added: "This study is an excellent demonstration that topical CBD can really help people with arthritis in their hands.

"The study showed significant improvement not only in pain but also in grip strength, fatigue, stiffness and anxiety.

"This shows how useful a simple CBD gel can be - being able to move the hand with less pain can really help with daily tasks like cooking, dressing and holding and using a mobile phone, for example.

"Certainly, it is just an exploratory study but one that shows the great potential for CBD gel."

Various studies show CBD pain relief connection

This pilot study demonstrated that transdermal CBD may provide some promise for a safe treatment option for symptomatically active hand osteoarthritis.

The study backs up previous research on the potential therapeutic effects of CBD creams (https://hempwell.co.uk/collections/cbd-creams/) on chronic pain.

For example, a 2018 review (Bruni, Della Peppa, Oliaro-Bosso et al) of 79 clinical studies found that there was moderate-quality evidence Cannabinoids may be effective in reducing chronic pain associated with rheumatoid arthritis.

A further 2013 study (Fine, Rosenfeld, 2013) suggests that CBD and other cannabinoids may help reduce chronic pain by interacting with the body's endocannabinoid system, which plays a role in regulating pain sensation, mood, and other physiological processes.

Study statistics:

• 15 people completed the trial
• Pain ratings were significantly reduced over time from the pre-treatment baseline
• These included reductions in current pain, average pain and maximum pain